Hospital

Marilyn Bulloch, PharmD, BCPS, FCCM, shares her perspective of how the global COVID-19 pandemic is impacting pharmacy in her Alabama community.

Top news of the week from Pharmacy Times surrounding the novel coronavirus.

Chloroquine and remdesivir are not FDA-approved for a COVID-19 indications.

The researchers found that the average yearly out-of-pocket spending by patients with diabetes is over $1,800.

The availability of personal protective equipment, including face masks, gloves and hand sanitizers, have been a concern to many pharmacists.

The goals of the expansion are to maintain social distancing and to avoid overburdening hospitals with patients.

Aimmune’s peanut allergen power was approved by the FDA as an oral immunotherapy indicated for the mitigation of allergic reactions, including anaphylaxis, that may occur with accidental exposure to peanut.

The new guidance for industry (GFI) document, “Policy for Temporary Compounding of Certain Alcohol-Based Hand Sanitizer Products,” was released Saturday.

In its first action, the FDA has decided to not object to the New York State Department of Health’s (NYSDOH) action authorizing certain laboratories in New York to start patient testing for COVID-19.

Illustrating how pharmacists improve the lives of others in the health environment, and using data to back that up are the 2 most necessary steps in gaining approval for a new hire.

Cannabis is comprised of over 480 compounds and 70 distinct cannabinoids, but tetrahydrocannabinol (THC) and cannabidiol (CBD) are the 2 most commonly used.

Novel approaches such as telemedicine may be a way to reach rural patients with cancer, according to a panel discussion at the Hematology/Oncology Pharmacists Association 2020 Meeting

Lesbian, gay, bisexual, transgender, and queer (LGBTQ) patients with cancer face specific barriers when seeking medical care, but pharmacists and other medical professionals can take specific steps to reduce the gaps in care.

Some of the candidates are approved by the FDA for other indications, but the majority of the agents are not currently commercially available in the United States for therapeutic use.

Service outcomes will be optimized by considering a constellation of factors besides the service itself, such as social support and patient self-efficacy.

In the United States, the CDC has confirmed 938 cases and 29 deaths, as well as 771 patients under investigation.

As vaping continues to grow in popularity, it becomes increasingly critical to correct misconceptions about its safety and long-term effects.

The FDA is taking action against companies that claim to treat or prevent the virus.

Health care spending increased by 4.4% in 2018, slightly more than the 4.2% increase in 2017, and the third consecutive year with an increase greater than 4%.

Rotovirus infection is a hypothesized risk factor for type 1 diabetes, according to the authors.

The act aims to mitigate common triggers of drug shortages by improving transparency throughout the drug supply chain process, and strengthening FDA interagency efforts to prevent shortages.

Pharmacy managers invariably face employees suffering from various personal issues that require special attention and/or counseling, and at some point will be confronted with the issue of an impaired employee.

The greatest risk is still to people who have been in close contact with COVID-19 patients, according to the CDC.

If severe, toxoplasmosis can cause damage to the brain, eyes, or other organs.

The medication works by blocking CGRP receptors, treating a root cause of migraine.

A study published in Neuron suggests that targeting astrocyte calcium signaling could decrease the behavioral effects of amphetamine.

The product will be immediately launched with limited commercial qualities, and manufacturers expect that there will be a steady supply by the fourth quarter of 2020.

The new drug is a nonopioid therapeutic option for patients experiencing moderate to severe pain.

Fears surrounding the COVID-19 outbreak have had major effects even in unaffected areas, including face mask shortages, a falling stock market, and many unsubstantiated rumors.

Pharmacists are the primary drivers of their destiny, according to a new report, and they will continue to drive change in the industry by demonstrating their value, securing compensation, and advocating for expanded roles.